Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 781684, 12 pages
http://dx.doi.org/10.1155/2014/781684
Research Article

Preliminary Study of Quercetin Affecting the Hypothalamic-Pituitary-Gonadal Axis on Rat Endometriosis Model

1Department of Obstetrics and Gynecology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China
2Department of Traditional Chinese Medicine, The First People’s Hospital of Yinchuan, Ningxia 750001, China
3Department of Reproductive Pharmacology, NPFPC Key Laboratory of Contraceptives and Devices, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China

Received 15 June 2014; Revised 30 August 2014; Accepted 1 September 2014; Published 28 October 2014

Academic Editor: Karl Wah-Keung Tsim

Copyright © 2014 Yang Cao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Matarese, G. de Placido, Y. Nikas, and C. Alviggi, “Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease?” Trends in Molecular Medicine, vol. 9, no. 5, pp. 223–228, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. García Manero, B. Olartecoechea, P. Royo Manero, M. Aubá, and G. López, “Endometriosis,” Revista de Medicina de la Universidad de Navarra, vol. 53, no. 2, pp. 4–7, 2009. View at Google Scholar · View at Scopus
  3. S. H. Kim, H. D. Chae, C. H. Kim, and B. M. Kang, “Update on the treatment of endometriosis,” Clinical and Experimental Reproductive Medicine, vol. 40, no. 2, pp. 55–59, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Platteeuw and T. D'Hooghe, “Novel agents for the medical treatment of endometriosis,” Current Opinion in Obstetrics & Gynecology, vol. 26, no. 4, pp. 243–252, 2014. View at Publisher · View at Google Scholar
  5. M. Wiksten-Almströmer, A. Lindén Hirschberg, and K. Hagenfeldt, “Menstrual disorders and associated factors among adolescent girls visiting a youth clinic,” Acta Obstetricia et Gynecologica Scandinavica, vol. 86, no. 1, pp. 65–72, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. X.-H. Deng, H.-Y. Song, Y.-F. Zhou, G.-Y. Yuan, and F.-J. Zheng, “Effects of quercetin on the proliferation of breast cancer cells and expression of survivin in vitro,” Experimental and Therapeutic Medicine, vol. 6, no. 5, pp. 1155–1158, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Derakhshanian, M. Djalali, A. Djazayery et al., “Quercetin prevents experimental glucocorticoid-induced osteoporosis: a comparative study with alendronate,” Canadian Journal of Physiology and Pharmacology, vol. 91, no. 5, pp. 380–385, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. W.-T. Zhang, Y.-J. Zhong, Q.-Y. Lü, and J. Cheng, “Impact of quercetin on the expression of heparanase in cervical cancer cells,” Zhonghua fu chan ke za zhi, vol. 48, no. 3, pp. 198–203, 2013. View at Google Scholar · View at Scopus
  9. X. Zhang, X. Wang, H. J. Wang, Q. Yang, and M. R. Qie, “Inhibition effect and mechanisms of quercetin on surgically induced endometriosis,” Journal of Sichuan University, vol. 40, no. 2, pp. 228–244, 2009. View at Google Scholar · View at Scopus
  10. R. C. Jones, “The effect of a luteinizing hormone releasing hormone (LRH) agonist (Wy-40,972), levonorgestrel, danazol and ovariectomy on experimental endometriosis in the rat,” Acta Endocrinologica, vol. 106, no. 2, pp. 282–288, 1984. View at Google Scholar · View at Scopus
  11. W. Wang, Y. Li, M. Maitituoheti et al., “Association of an oestrogen receptor gene polymorphism in Chinese Han women with endometriosis and endometriosis-related infertility,” Reproductive BioMedicine Online, vol. 26, no. 1, pp. 93–98, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S. E. Bulun, D. Monsavais, M. E. Pavone et al., “Role of estrogen receptor-β in endometriosis,” Seminars in Reproductive Medicine, vol. 30, no. 1, pp. 39–45, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. T. A. H. Jarvinen, M. Pelto-Huikko, K. Holli, and J. Isola, “Estrogen receptor β is coexpressed with ERα and PR and associated with nodal status, grade, and proliferation rate in breast cancer,” The American Journal of Pathology, vol. 156, no. 1, pp. 29–35, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Fester, J. Labitzke, R. Hinz et al., “Estradiol responsiveness of synaptopodin in hippocampal neurons is mediated by estrogen receptor β,” Journal of Steroid Biochemistry and Molecular Biology, vol. 138, pp. 455–461, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Guo, S. J. Zhang, and Q. P. Tang, “Effects of estrogen receptors in the pituitary,” Life Science, vol. 23, no. 10, pp. 975–979, 2011. View at Google Scholar
  16. S. C. Hewitt, J. C. Harrell, and K. S. Korach, “Lessons in estrogen biology from knockout and transgenic animals,” Annual Review of Physiology, vol. 67, pp. 285–308, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. C. D. Toran-Allerand, “Minireview: a plethora of estrogen receptors in the brain: where will it end?” Endocrinology, vol. 145, no. 3, pp. 1069–1074, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Sánhez-Criado, J. C. Garrido-Gracia, C. Bellido et al., “Oestradiol-17β inhibits tamoxifen-induced LHRH self-priming blocking hormone-dependent and ligand-independent activation of the gonadotrope progesterone receptor in the rat,” Journal of Endocrinology, vol. 190, no. 1, pp. 73–84, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Yang, Y.-J. Tian, and M.-X. Ding, “Effects of mifepristone and gestrinone on proliferation of endometrial stromal cells,” Journal of Practical Gynecology and Obstetrics, vol. 23, no. 7, pp. 419–421, 2007. View at Google Scholar
  20. H. A. Harris, K. L. Bruner-Tran, X. Zhang, K. G. Osteen, and C. R. Lyttle, “A selective estrogen receptor-β agonist causes lesion regression in an experimentally induced model of endometriosis,” Human Reproduction, vol. 20, no. 4, pp. 936–941, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Bovet, B. Plet, M. Ruff et al., “Towards high-throughput identification of endocrine disrupting compounds with mass spectrometry,” Toxicology in Vitro, vol. 23, no. 4, pp. 704–709, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Lehmann, L. Jiang, and J. Wagner, “Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells,” Carcinogenesis, vol. 29, no. 2, pp. 363–370, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. A. M. Sotoca, D. Ratman, P. van der Saag et al., “Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERα/ERβ ratio,” Journal of Steroid Biochemistry and Molecular Biology, vol. 112, no. 4-5, pp. 171–178, 2008. View at Publisher · View at Google Scholar · View at Scopus